The serum hepatitis C virus RNA at two weeks after the administration of interferon: Its predictability for the efficacy of interferon treatment for chronic hepatitis C

Nihon University Journal of Medicine

Volumn 40, Issue 1, 1998, Pages 61-69

  Matsumura, Hiroshi ^a   Moriyama, Mitsuhiko ^b   Tanaka, Naohide ^b   Okubo, Hitoshi ^b   Uchida, Toshikazu ^b   Arakawa, Yasuyuki ^b  

^a NIHON UNIVERSITY   (Japan)

^b NONE

Author keywords

Chronic hepatitis C; Efficacy of interferon; Serum HCV RNA; Two weeks after start of interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CLINICAL PROTOCOL; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; RECURRENCE RISK; REMISSION; RISK ASSESSMENT; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS GENE;

EID: 0031951459     PISSN: 05460352     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hoofnagle, J.H., Mullen, K.D., Jones, D.B., Rustgi, V., ADi, Bisceglia, Peters, M., Waggoner, J.G., Park, Y. and Jones, E.A.: Treatment of chronic non A, non B hepatitis with recombinant human alpha interferon. N. Engl. J. Med. 315 1575-1578 (1986)
2. Choo, Q.L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W. and Houghton, M.: Isolation of a cDNA clone derived from a blood-borne non-A, non-B, viral hepatitis genome. Science 244 359-362 (1989)
3. Kuo, G., Choo, Q.L., Alter, H.J., Gitnick, G.L., Redeker, A.G., Purcell, R.H., Miyamura, T., Dienstag, J.L., Alter, M.J. and Stevens, C.E.: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244 362-364 (1989)
4. Di Bisceglie, A.M., Martin, P., Kassianides, C., Lisker, M., Goodman, Z., Banks, S.M. and Hoofnagel, J.H.: Recombinant interferon alpha therapy for chronic hepatitis C. N. Engl. J. Med. 321 1506-1510 (1989)
5. Iino, S., Hino, K. and Yasuda, K.: Current state of interferon therapy for chronic hepatitis C. Intervirology 37 87-100 (1994)
6. Uchida, T., Taira, M., Shikata, T., Moriyama, M., Tanaka, N., Okubo, H. and Arakawa, Y.: Histological difference between complete responders and non-responders to interferon therapy to the livers of patients with chronic hepatitis C. Acta Pathol. Jpn. 43 230-236 (1993)
7. Uchida, T.: Pathology of hepatitis C. Intervirology 37 126-132 (1994)
8. Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Ogura, Y., Izumi, N., Marumo, F. and Sato, C.: Mutation in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med. 334 77-81 (1996)
9. Chomczynski, P. and Sacchi, N.: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 156-159 (1987)
10. Inchauspe, G., Abe, K., Zebedee, S., Nasoff, M. and Prince, A.M.: Use of conserved sequences from hepatitis C virus for the detection of viral RNA in infected sera by polymerase chain reaction. Hepatology 14 595-600 (1991)
11. Okamoto, H., Sugiyama, Y., Okada, S., Kurai, K., Akahane, Y., Sugai, Y., Tanaka, T., Sato, K., Tsuda, F., Miyakawa, Y. and Mayumi, M.: Typing of hepatitis C virus by PCR with type-specific primers: application to clinical surveys and tracing infectious sources. J. Gen. Virol. 73 673-679 (1992)
12. Simmonds, P., Alberti, A., Alter, J., Bonino, F., Bradley, D.W., Brechet, C., Brouwer, J.T., Chan, S.W., Chayama, K., Chen, D.S., Choo, Q.L., Colombo, M., Cuypers, H.T.M., Date, T., Dusheiko, G.M., Esteban, J.I., Fay, O., Hadziyannis, S.J., Han, J., Hatzakis, A., Holmes, E.C., Hotta, H., Houghton, M., Irvine, B., Kohara, M., Kolberg, J.A., Kuo, G., Lau, J.Y.N., Lelie, P.N., Maertens, G., Mcomish, F., Miyamura, T., Mizokami, M., Nomoto, A., Prince, A.M., Reesink, H.W., Rice, C., Roggendorf, M., Schalm, S.W., Shikata, T., Shimotohno, K., Stuyver, L., Trepo, C., Weiner, A., Yap, P.L. and Urdea, M.S.: A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19 1321-1324 (1994)
13. Kato, N., Yokosuka, O., Hosoda, K., ito, Y., Ohto, M. and Omata, M.: Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease. Hepatology 18 16-20 (1993)
14. Orito, E., Mizokami, M., Suzuki, K., Obha, K., Ohno, T., Mori, M., Hayashi, K., Kato, K., Iino, S. and Lau, J.Y.N.: Loss of serum HCV RNA at week 4 of interferon-α therapy is associated with more favorable long-term response in patients with chronic hepatitis C. J. Med. Virol. 46 109-115 (1995)
15. Karino, Y., Toyota, J., Sugawara, M., Higashino, K., Sato, T., Ohmura, T., Suga, T., Okuuchi, Y. and Matsushima, T.: Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C. Am. J. Gastroenterol. 92(1) 61-65 (1997)
16. Boucher, E., Jouanolle, H., Andre, P., Ruffault, A., Guyader, D., Moirand, R., Turlin, B., Jacquelinet, C., Brissot, P. and Deugnier, Y.: Interferon and ursodeoxycholic acid combined therapy in the treatment of chronic viral C hepatitis: Results from a controlled randomized trial in 80 patients. Hepatology 21 322-327 (1995)
17. Saito, H., Ebinuma, H. and Tada, S.: Enhancing effect of the liver extract and flavin adenin dinucleotide mixture on anti viral efficacy of interferon in patients with chronic hepatitis C. Keio J. Med. 45(1) 48-58 (1996)
18. Nishiguchi, S., Kuroki, T., Nakatani, S., Morimoto, H., Takeda, T., Nakajima, S., Shiomi, S., Seki, S., Kobayashi, K. and Otani, S.: Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346 1051-1055 (1995)
19. Tarao, K., Shimizu, A., Ohkawa, S. and Tamai, S.: High risk group of HCC development from HCV-associated liver cirrhosis (in Japanese). Nippon Naika Gakkai Zasshi 84 1985-1991 (1995)
20. Tarao, K., Takemiya, S., Tamai, S., Sugimasa, Y., Ohkawa, S., Akaike, M., Tanabe, H., Shimizu, A., Yoshida, M. and Kakita, A.: Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. Cancer 79(4) 688-694 (1997)